We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone.
- Authors
Vosooghi, Mohsen; Yahyavi, Hoda; Divsalar, Kouros; Shamsa, Hashem; Kheirollahi, Asma; Safavi, Maliheh; Kabudanian Ardestani, Sussan; Sadeghi-Neshat, Sareh; Mohammadhosseini, Negar; Edraki, Najmeh; Khoshneviszadeh, Mehdi; Shafiee, Abbas; Foroumadi, Alireza
- Abstract
Background and the purpose of the study: Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. Methods: The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. Results: The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC50 values were 0.6 and 1.7 μM; respectively). Conclusion: The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.
- Subjects
DEHYDROEPIANDROSTERONE; RESEARCH methodology; RESEARCH funding; TISSUE culture; TUMORS; IN vitro studies
- Publication
DARU: Journal of Pharmaceutical Sciences, 2013, Vol 21, p1
- ISSN
1560-8115
- Publication type
Article
- DOI
10.1186/2008-2231-21-34